These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 29066693)
1. [The Impact of Neutrophil-Lymphocyte Ratio on the Prognosis in Patients Who Underwent Esophagectomy for Esophageal Cancer]. Muroya T; Wajima N; Ogasawara H; Yachi T; Akaishi T; Umetsu S; Wakasa Y; Yoshida T; Sato K; Mitsuhashi Y; Umemura K; Suzuki T; Tsuruta S; Hakamada K Gan To Kagaku Ryoho; 2017 Oct; 44(10):912-914. PubMed ID: 29066693 [TBL] [Abstract][Full Text] [Related]
2. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma. Xiao Q; Zhang B; Deng X; Wu J; Wang H; Wang Y; Wang W PLoS One; 2016; 11(12):e0168299. PubMed ID: 27959959 [TBL] [Abstract][Full Text] [Related]
3. Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer. Nakamura K; Yoshida N; Baba Y; Kosumi K; Uchihara T; Kiyozumi Y; Ohuchi M; Ishimoto T; Iwatsuki M; Sakamoto Y; Watanabe M; Baba H Int J Clin Oncol; 2017 Jun; 22(3):469-475. PubMed ID: 28097441 [TBL] [Abstract][Full Text] [Related]
4. [Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after radical resection of esophageal squamous cell carcinoma]. Chen H; He J Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):294-7. PubMed ID: 24989917 [TBL] [Abstract][Full Text] [Related]
5. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study. Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy. Hirahara N; Matsubara T; Mizota Y; Ishibashi S; Tajima Y BMC Surg; 2016 Sep; 16(1):66. PubMed ID: 27650456 [TBL] [Abstract][Full Text] [Related]
8. Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of esophageal squamous cell cancer patients undergoing minimally invasive esophagectomy after neoadjuvant chemotherapy. Kato T; Oshikiri T; Goto H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Nakamura T; Suzuki S; Kakeji Y J Surg Oncol; 2021 Dec; 124(7):1022-1030. PubMed ID: 34460103 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma. Jung J; Park SY; Park SJ; Park J Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960 [TBL] [Abstract][Full Text] [Related]
10. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Sharaiha RZ; Halazun KJ; Mirza F; Port JL; Lee PC; Neugut AI; Altorki NK; Abrams JA Ann Surg Oncol; 2011 Nov; 18(12):3362-9. PubMed ID: 21547702 [TBL] [Abstract][Full Text] [Related]
11. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation. Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933 [TBL] [Abstract][Full Text] [Related]
12. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction. Yuan D; Zhu K; Li K; Yan R; Jia Y; Dang C J Surg Oncol; 2014 Sep; 110(3):333-40. PubMed ID: 24889121 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with Esophageal Cancer. Ishibashi Y; Tsujimoto H; Hiraki S; Kumano I; Yaguchi Y; Horiguchi H; Nomura S; Ito N; Shinto E; Aosasa S; Yamamoto J; Ueno H Ann Surg Oncol; 2018 Oct; 25(11):3288-3299. PubMed ID: 30019304 [TBL] [Abstract][Full Text] [Related]
14. Significance of blood neutrophil-to-lymphocyte ratio for prognostic stratification of patients with gastroesophageal junction adenocarcinoma in the era of the 8th edition of the American Joint Committee on Cancer (AJCC8) staging. Conway AM; Salih Z; Papaxoinis G; Fletcher K; Weaver J; Patrao A; Noble R; Stamatopoulou S; Owen-Holt V; Mansoor W Med Oncol; 2017 Jun; 34(6):116. PubMed ID: 28500616 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis and survival values of neutrophil-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in esophageal cancer. Han F; Liu Y; Cheng S; Sun Z; Sheng C; Sun X; Shang X; Tian W; Wang X; Li J; Liu D; Wang Y; Zhang B; Ju Y Clin Chim Acta; 2019 Jan; 488():150-158. PubMed ID: 30389457 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Importance of Controlling Nutritional Status in Patients Undergoing Curative Thoracoscopic Esophagectomy for Esophageal Cancer. Hirahara N; Matsubara T; Hayashi H; Takai K; Nakada S; Tajima Y Am J Ther; 2018; 25(5):e524-e532. PubMed ID: 26866437 [TBL] [Abstract][Full Text] [Related]
17. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer. Shao N; Cai Q Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392 [TBL] [Abstract][Full Text] [Related]
18. Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients. Kosumi K; Baba Y; Ishimoto T; Harada K; Nakamura K; Ohuchi M; Kiyozumi Y; Izumi D; Tokunaga R; Taki K; Higashi T; Miyata T; Kurashige J; Hiyoshi Y; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Baba H Surg Today; 2016 Apr; 46(4):405-13. PubMed ID: 26036223 [TBL] [Abstract][Full Text] [Related]
19. [Neutrophil-to-lymphocyte ratio predicts the survival in patients with post-operative recurrence of non-small cell lung cancer]. Wang X; Li K Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):298-302. PubMed ID: 24989918 [TBL] [Abstract][Full Text] [Related]
20. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer. Tustumi F; Takeda FR; Viyuela MS; da Cruz Junior JB; Brandão AAGS; Sallum RAA; Ribeiro Junior U; Cecconello I J Surg Oncol; 2020 Apr; 121(5):784-794. PubMed ID: 31762058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]